Cargando…
Tumor-infiltrating lymphocytes and CD8(+) T cells predict survival of triple-negative breast cancer
PURPOSE: Tumor inflammatory response was evaluated as a prognostic feature in triple-negative breast cancer (TNBC) and compared with the clinical prognosticators of breast cancer and selected biomarkers of cancer cell proliferation. METHODS: TNBC patients (n = 179) with complete clinical data and up...
Autores principales: | Vihervuori, H., Autere, T. A., Repo, H., Kurki, S., Kallio, L., Lintunen, M. M., Talvinen, K., Kronqvist, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861359/ https://www.ncbi.nlm.nih.gov/pubmed/31562550 http://dx.doi.org/10.1007/s00432-019-03036-5 |
Ejemplares similares
-
Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation
por: Vihervuori, H., et al.
Publicado: (2022) -
A prognostic model based on cell-cycle control predicts outcome of breast cancer patients
por: Repo, Heli, et al.
Publicado: (2020) -
PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival
por: Repo, Heli, et al.
Publicado: (2017) -
LAG-3(+) tumor-infiltrating lymphocytes ameliorates overall survival in triple-negative breast cancer patients
por: Hu, Guoming, et al.
Publicado: (2023) -
Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
por: Huertas-Caro, Carlos Alexander, et al.
Publicado: (2022)